CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-09 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −600 | 371,086 | ||
| 2025-12-03 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +5,000 | $0.06 | $300 | 5,000 |
| 2025-12-03 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −5,000 | $3.52 | $18K | 0 |
| 2025-12-03 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 371,686 | ||
| 2025-12-02 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +1,500 | $0.06 | $90 | 1,500 |
| 2025-12-02 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −1,500 | $3.91 | $6K | 0 |
| 2025-12-02 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 376,686 | ||
| 2025-11-25 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +5,965 | $0.06 | $358 | 11,930 |
| 2025-11-25 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −5,965 | $3.90 | $23K | 5,965 |
| 2025-11-25 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,965 | 378,186 | ||
| 2025-11-24 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +535 | $0.06 | $32 | 535 |
| 2025-11-24 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −535 | $3.94 | $2K | 0 |
| 2025-11-24 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −535 | 384,151 | ||
| 2025-11-18 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2025-11-18 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $3.75 | $24K | 0 |
| 2025-11-18 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 384,686 | ||
| 2025-11-10 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2025-11-10 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $4.10 | $27K | 0 |
| 2025-11-10 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 391,186 | ||
| 2025-11-07 | Marshall Richard Peter Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 5 of 12 · 223 trades